FluGen to Study Versatility of Its Universal Flu Vaccine Candidate

FluGen to Study Versatility of Its Universal Flu Vaccine Candidate

Source: 
Xconomy
snippet: 

One company developing an experimental universal flu vaccine is FluGen, a Madison, WI-based startup that on Wednesday announced it had kicked off a human clinical trial to test its vaccine candidate’s ability to protect against so-called drifted—or mismatched—flu strains.